Debra Reisenthel

Debra is an experienced medical device and digital health CEO with a passion for breakthrough products and services that improve health, well-being, and quality of life. She has broad operational and leadership roles in start-ups, corporate, and nonprofit organizations. Debra has a successful record of fundraising from venture capital, angel investors and non-profit donors, with significant expertise in working with government agencies, such as FDA and CMS in overcoming regulatory & reimbursement obstacles.

As Founding CEO of Freespira Inc., Debra grew the company from 2013-2018 by leading programs to expand Freespira’s evidence base with clinical trials for panic, PTSD, and adolescents while driving a health economics study with a large payer. She also established relationships with leading payors and employers while managing the development and launch of the Freespira treatment for panic disorder, panic attacks, and PTSD. Debra brings a unique blend of experience to Freespira, having successfully led early-stage ventures and leveraging her expertise in respiratory physiology.

Debra holds a B.A. in Applied Behavioral Sciences, an MBA, and R.R.T credentials.